Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis
- Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia. Buchel, O.; Roskams, T.; van Damme, B.; Nevens, F.; Pirenne, J.; Fevery, J. // Gut;Jul2005, Vol. 54 Issue 7, p1021
A male patient with portal hypertension, portal vein thrombosis, spontaneous splenorenal shunt formation, and encephalopathy, thought to have post-hepatitis B cirrhosis, is described. His condition deteriorated and necessitated liver transplantation. In the explant liver, nodular regenerative...
- Hepatitis A, B, G cases drop dramatically over 10 years. // East Bernard Express (TX);3/22/2007, Vol. 64 Issue 12, p5
The article reports that Hepatitis A, B, C cases in the U.S. drop dramatically over 10 years, between 1995 and 2005, according to the Center for Disease Control and Prevention.
- Viral hepatitis-related acute liver failure Vinholt Schiødt, Frank; Davern, Timothy J.; Obaid Shakil, A.; McGuire, Brendan; Samuel, Grace; Lee, William M. // American Journal of Gastroenterology;Feb2003, Vol. 98 Issue 2, p448
: ObjectivesViral hepatitis has previously been the major cause of acute liver failure (ALF) in the United States. We aimed to determine the incidence of viral hepatitis-related ALF and to compare the outcome and clinical and biochemical variables in patients with hepatitis A and B.: MethodsA...
- Laboratory approach to acute and chronic hepatitis. Dufour, D. Robert // MLO: Medical Laboratory Observer;Sep2003, Vol. 35 Issue 9, p10
Discusses acute and chronic hepatitis in the U.S. Patterns of liver injury; List of agents associated with viral hepatitis; Laboratory features of the most common causes of acute hepatitis. INSET: CE CONTINUING EDUCATION.
- Fighting Fire With Fire: Effects of Oncolytic Virotherapy on Underlying Viral Hepatitis in Hepatocellular Carcinoma. Reid, Tony // Molecular Therapy;Sep2008, Vol. 16 Issue 9, p1521
The article offers information on the effects of oncolytic virotherapy on underlying viral hepatitis in hepatocellular carcinoma (HCC). It states that HCC is considered as the fifth most common cancer in the world and the third most common reason of cancer-related deaths. Moreover, it is posed...
- Adequate Interval For Hepatocellular Carcinoma Surveillance. Giannini, Edoardo G; Farinati, Fabio; Trevisani, Franco // American Journal of Gastroenterology;Jul2013, Vol. 108 Issue 7, p1174
A letter to the editor is presented in response to the article "Hepatocellular Carcinoma Surveillance At 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community" by J. H. Wang and colleagues in the 2013 issue.
- Response to Giannini et al. Wang, Jing-Houng; Lu, Sheng-Nan // American Journal of Gastroenterology;Jul2013, Vol. 108 Issue 7, p1175
A response from the author of the article "Hepatocellular Carcinoma Surveillance At 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community" in the 2013 issue is presented.
- Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil. // Journal of Antimicrobial Chemotherapy (JAC);May2007, Vol. 59 Issue 5, p827
Most chronic hepatitis B patients do not undergo a curative response to interferon-Î± or nucleoside/nucleotide-based regimens and require long-term therapy. Long-term safety, efficacy and resistance profiles of hepatitis B virus (HBV) drugs are therefore crucial issues for patient management....
- Non-A, Non-B Hepatitis: Sorting through a Diagnosis of Exclusion. Alter, Miriam J. // Annals of Internal Medicine;4/15/89, Vol. 110 Issue 8, p583
Editorial. Discusses the consideration of non-A, non-B hepatitis by a diagnosis of exclusion since the development of diagnostic tests for hepatitis B virus and its elimination as a major cause of transfusion-associated hepatitis. Types of non-A, non-B hepatitis which are probably causes by...